Calls for papers
-
We are currently seeking a Device Senior Scientist for our Global Pharmaceutical client based in the Dublin area, due to major growth at the company they are looking to add to their team. Ref: 5040182… Read more . . .
-
Our client a global pharmaceutical company are currently seeking an Assembly & Packaging Manager to join their organisation. Ref: 5040178 Role/Opportunity: • Device assembly and/or packaging engineer responsible for leading and managing the final drug-device… Read more . . .
-
Berkley Pharma & Life Science are currently seeking a QA Manager/QP for our client a Global pharmaceutical company based in Dublin. Ref: 5040183 Role/Opportunity: • To manage and lead the Pilot Plant site Quality Assurance… Read more . . .
-
Berkley Pharma & Life Science are currently seeking an Equipment Senior Scientist for our client, a leading pharmaceutical company based in Dublin. Ref: 5040180 Role/Opportunity: • Seeking an experienced Manufacturing Equipment specialist with a good… Read more . . .
-
Consort Medical has announced record revenue and profits for the year ending April 30, 2012, including a 12% increase in revenue for its Bespak division, which manufactures metered dose inhaler valves and actuators as well… Read more . . .
-
Contract particle characterization specialist Gateway Analytical has announced that it will host the 2012 Inhalation and Nasal Technology Focus Group (INTFG) Annual Fall Symposium on September 7, 2012 at the Pittsburgh North Marriott in Cranberry,… Read more . . .
-
Submit poster abstracts by August 19, 2012 at the INTFG submission site. Submissions on any inhalation or nasal drug technology topic are welcome. More information. Read more . . .
-
Savara Pharmaceuticals has announced positive top-line results from a Phase 1 study of its AeroVanc inhaled dry powder formulation of vancomycin for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with cystic fibrosis.… Read more . . .
-
Entries submitted to several student inhaler and medical device design contests over the past year envision some radical changes in inhaler design. These concepts, created by students who range in age from primary school through… Read more . . .
-
Pharmaxis has submitted an NDA for Bronchitol inhaled dry powder mannitol for the treatment of cystic fibrosis to the FDA. Pharmaxis CEO Dr Alan Robertson said, “The submission marks the second of two key milestones… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan